Type of regimen | No. of courses | No. of patients | % |
Nab-paclitaxel, 260 mg/m2, q3w | 4 | 22 | 26.2 |
Followed by epirubicin, 90 mg/m2 + cyclophosphamide, 600 mg/m2, q3w | 4 | ||
Epirubicin, 90 mg/m2 + cyclophosphamide, 600 mg/m2, q3w | 4 | 30 | 35.7 |
Followed by docetaxel, 75 mg/m2, q3w | 4 | ||
Docetaxel, 75 mg/m2 + doxorubicin, 50 mg/m2 + cyclophosphamide, 500 mg/m2, q3w | 4 | 1 | 1.2 |
Fluorouracil, 500 mg/m2 + epirubicin, 90 mg/m2 + cyclophosphamide, 500 mg/m2, q3w | 4 | 2 | 2.3 |
Followed by docetaxel, 75 mg/m2, q3w | 4 | ||
Fluorouracil, 500 mg/m2 + epirubicin, 90 mg/m2 + cyclophosphamide, 500 mg/m2, q3w | 4 | 4 | 4.8 |
Followed by docetaxel, 75 mg/m2 + trastuzumab, 6 mg/kg, q3w* | 4 | ||
Carboplatin AUC6 + docetaxel, 75 mg/m2 + trastuzumab, 6 mg/kg, q3w* | 6 | 15 | 17.9 |
Paclitaxel, 90 mg/m2, qw×3 + bevacizumab, 10 mg/kg, q2w×2 | 6 | 10 | 11.9 |
↵* Initial dose of trastuzumab was 8 mg/kg.
Nab = nanoparticle albumin–bound.